Anchor Capital Advisors LLC Harrow Health, Inc. Transaction History

Anchor Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$17.37 - $28.08 $580,696 - $938,742	-33,431 Reduced 56.32%	25,923 $493,000
Q1 2023 May 03, 2023	SELL	$13.84 - $21.46 $1.74 Million - $2.7 Million	-126,003 Reduced 67.98%	59,354 $1.26 Million
Q4 2022 Feb 10, 2023	SELL	$10.28 - $14.78 $533,069 - $766,416	-51,855 Reduced 21.86%	185,357 $2.74 Million
Q3 2022 Nov 09, 2022	BUY	$6.57 - $24.88 $74,241 - $281,144	11,300 Added 5.0%	237,212 $2.86 Million
Q2 2022 Aug 04, 2022	BUY	$5.75 - $7.74 $60,225 - $81,068	10,474 Added 4.86%	225,912 $1.65 Million
Q1 2022 May 06, 2022	BUY	$6.77 - $8.66 $191,002 - $244,324	28,213 Added 15.07%	215,438 $1.47 Million
Q4 2021 Feb 10, 2022	SELL	$8.5 - $12.0 $67,175 - $94,836	-7,903 Reduced 4.05%	187,225 $1.62 Million
Q3 2021 Nov 02, 2021	SELL	$6.99 - $10.6 $42,680 - $64,723	-6,106 Reduced 3.03%	195,128 $1.77 Million
Q2 2021 Aug 16, 2021	SELL	$6.68 - $11.07 $49,017 - $81,231	-7,338 Reduced 3.52%	201,234 $1.87 Million
Q1 2021 May 14, 2021	BUY	$6.26 - $11.03 $1.31 Million - $2.3 Million	208,572 New	208,572 $1.41 Million

176

21.3M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $885M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Anchor Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Anchor Capital Advisors LLC with notifications on news.